Results 71 to 80 of about 4,524 (132)

Targeting Thrombopoietin/MPL Signaling to Mitigate JAK2V617F-Driven Cardiac Microvascular Disease. [PDF]

open access: yesArterioscler Thromb Vasc Biol
Yang X   +6 more
europepmc   +1 more source

Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026. [PDF]

open access: yesCurr Hematol Malig Rep
Abu-Zeinah G   +18 more
europepmc   +1 more source

Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasms. [PDF]

open access: yesCell Commun Signal
Weiand P   +12 more
europepmc   +1 more source

Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the <i>JAK2V617F</i> Variant Allele Frequency in Myeloproliferative Neoplasms. [PDF]

open access: yesCancers (Basel)
Bistrup CN   +8 more
europepmc   +1 more source

Single-cell long-read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML. [PDF]

open access: yesBlood Adv
Grabek J   +15 more
europepmc   +1 more source

JAK2<sup>V617F</sup>-positive clonal hematopoiesis in germline BRCA1 versus BRCA2 mutation carriers. [PDF]

open access: yesLeukemia
Rodriguez MJ   +15 more
europepmc   +1 more source

Mathematical modeling of <i>JAK2V617F</i> clonal expansion in a general population cohort. [PDF]

open access: yesProc Natl Acad Sci U S A
Snyder J   +11 more
europepmc   +1 more source

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

open access: yesBlood
Uchida T   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy